Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.

Senturk H., Tahan V., Canbakan B., Uraz S., Ulger Y., Ozaras R., ...Daha Fazla

The Netherlands journal of medicine, cilt.66, ss.191-5, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 66
  • Basım Tarihi: 2008
  • Dergi Adı: The Netherlands journal of medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.191-5
  • Çukurova Üniversitesi Adresli: Hayır

Özet

Background: The effect of conventional interferon-based therapy of hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection is controversial. Yet, no studies have been carried out into pegylated interferon treatment for chronic HBV/HCV coinfection. We aimed to evaluate the response rate and side effects of conventional or pegylated interferon combined with ribavirin on chronic HBV/HCV coinfection therapy.